Talk:Arketamine

Contradictory statement of dopamine reuptake
"In rodent studies, esketamine produced hyperlocomotion, prepulse inhibition deficits, and rewarding effects, while arketamine did not, in accordance with its lower potency as an NMDA receptor antagonist and dopamine reuptake inhibitor"

This doesn't make sense as the page earlier says that R-ketamine is a stronger dopamine reuptake inhibitor than S-ketamine. The article provided as a source does not mention dopamine whatsoever. SSyntaxin (talk) 13:56, 3 September 2019 (UTC)